{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:35:34Z","timestamp":1794256534782,"version":"4.9.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.tjpad.2024.100001","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T10:27:31Z","timestamp":1736504851000},"page":"100001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundation"],"prefix":"10.1016","volume":"12","author":[{"given":"Jeffrey","family":"Cummings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mintun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Irizarry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"von Eschenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaycee","family":"Sink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaren","family":"Landen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miia","family":"Kivipelto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Grundman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Partrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Nisenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Burstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Fillit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2024.100001_bib0001","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.0000000000006745","article-title":"Translating the biology of aging into novel therapeutics for Alzheimer disease","volume":"92","author":"Hara","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2024.100001_bib0002","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158453","article-title":"Biological aging processes underlying cognitive decline and neurodegenerative disease","volume":"132","author":"Gonzales","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tjpad.2024.100001_bib0003","doi-asserted-by":"crossref","first-page":"620","DOI":"10.14283\/jpad.2023.103","article-title":"Geroscience and Alzheimer's Disease Drug Development","volume":"10","author":"Cummings","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2024.100001_bib0004","doi-asserted-by":"crossref","first-page":"164","DOI":"10.14283\/jpad.2019.12","article-title":"Combination Therapy for Alzheimer's Disease: perspectives of the EU\/US CTAD Task Force","volume":"6","author":"Gauthier","year":"2019","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2024.100001_bib0005","doi-asserted-by":"crossref","first-page":"e12073","DOI":"10.1002\/trc2.12073","article-title":"Advancing combination therapy for Alzheimer's disease","volume":"6","author":"Salloway","year":"2020","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.tjpad.2024.100001_bib0006","doi-asserted-by":"crossref","unstructured":"Cummings J., Zhou Y., Lee G., Zhong K., Fonseca J., Cheng F. Alzheimer's disease drug development pipeline: 2024. Alzheimer's & Dementia: translational Research & Clinical Interventions. 2024;10:e12465.https:\/\/doi.org\/10.1002\/trc2.12465","DOI":"10.1002\/trc2.12465"},{"key":"10.1016\/j.tjpad.2024.100001_bib0007","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjpad.2024.100001_bib0008","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in Early Symptomatic Alzheimer Disease: the TRAILBLAZER-ALZ 2 Randomized Clinical Trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.tjpad.2024.100001_bib0009","year":"2023","journal-title":"Prescribing Information. Eisai Inc. and Biogen"},{"key":"10.1016\/j.tjpad.2024.100001_bib0010","unstructured":"Kisunla. Prescribing Information. Eli Lilly and Company."},{"key":"10.1016\/j.tjpad.2024.100001_bib0011","doi-asserted-by":"crossref","first-page":"617","DOI":"10.14283\/jpad.2023.102","article-title":"The State of Alzheimer's Research and the Path Forward","volume":"10","author":"Fillit","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2024.100001_bib0012","unstructured":"Codevelopment of Two or More New Investigational Drugs for Use in Combination. Food and Drug Administration Center for Drug Evaluation and Research. 2013. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/codevelopment-two-or-more-new-investigational-drugs-use-combination. Accessed 29 July 2024."},{"key":"10.1016\/j.tjpad.2024.100001_bib0013","unstructured":"Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products. Food and Drug Administration Center for Biologics Evaluation and Research. 2020. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/interacting-fda-complex-innovative-trial-designs-drugs-and-biological-products Accessed 29 July 2024."},{"key":"10.1016\/j.tjpad.2024.100001_bib0014","first-page":"32","article-title":"Of adaptive and factorial designs","volume":"50","author":"Berry","year":"2024","journal-title":"The Cancer Letter"},{"key":"10.1016\/j.tjpad.2024.100001_bib0015","unstructured":"Secondary Prevention Trial (NexGen). The Dominantly Inherited Alzheimer Network. 2024. https:\/\/dian.wustl.edu\/our-research\/clinical-trial\/nexgen-trial\/.https:\/\/dian.wustl.edu\/our-research\/clinical-trial\/nexgen-trial\/. Accessed 29 July 2024."},{"key":"10.1016\/j.tjpad.2024.100001_bib0016","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14283\/jpad.2019.46","article-title":"The European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study: baseline Data Release V500.0","volume":"7","author":"Ritchie","year":"2020","journal-title":"J Prev Alzheimers Dis"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724005934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724005934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T10:27:38Z","timestamp":1736504858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724005934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2274580724005934"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2024.100001","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2024.100001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Alzheimer's Drug Discovery Foundation. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100001"}}